15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 0.0% per year over the past 5 years.
Financial health
Total debt has grown slower than revenue (-53.3% vs -0.0% per year).
Operating income covered interest expense -146.9× in the latest year.
The company is unprofitable; at its current free-cash-flow burn it has roughly 2.3 years of cash runway.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$26M
-$2M
28.3%
-7.4%
-6.4%
-5.8%
-$4M
—
$9M
2024
$27M
-$2M
22.5%
-9.0%
-7.5%
-6.0%
-$2M
$268000
$13M
2023
$24M
-$4M
21.0%
-20.2%
-16.0%
-11.9%
-$624000
$349000
$14M
2022
$26M
-$224000
25.7%
-7.1%
-0.8%
-0.6%
-$471000
$426000
$14M
2021
—
$5M
—
—
16.3%
13.4%
-$5M
$2M
$17M
2020
—
-$6M
—
—
-25.2%
-14.8%
-$3M
$14M
$8M
2019
—
-$6M
—
—
-21.1%
-13.5%
-$2M
$12M
$9M
2018
—
-$5M
—
—
-14.6%
-10.0%
-$2M
$13M
$11M
2017
—
$5M
—
—
13.2%
8.9%
-$3M
$14M
$14M
2016
—
-$149124
—
—
-0.4%
-0.3%
$9M
$3M
$22M
2015
—
$3M
—
—
9.6%
7.8%
$1M
$4M
$13M
2014
—
-$2M
—
—
-8.5%
-5.4%
$927486
$5M
$12M
2013
—
-$560323
—
—
-1.8%
-1.4%
-$3M
$5M
$11M
2012
—
$435586
—
—
1.4%
1.0%
-$12M
$8M
$14M
2011
—
$4M
—
—
12.5%
9.8%
$4M
$3M
$18M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$2M
$13M
16.8%
-79.8%
34.9%
32.6%
-$426000
—
$23M
Mar '26
$2M
-$2M
8.0%
-97.4%
-7.1%
-6.3%
-$865000
—
$8M
Dec '25
$5M
-$1M
22.2%
-27.2%
-5.1%
-4.6%
$398000
—
$9M
Sep '25
$7M
$384000
32.7%
4.2%
1.5%
1.3%
$1M
$203000
$8M
Jun '25
$3M
-$1M
14.1%
-40.3%
-4.2%
-3.5%
-$3M
$225000
$7M
Mar '25
$6M
$360000
27.4%
-5.1%
1.4%
1.2%
-$2M
$247000
$10M
Dec '24
$7M
$132000
26.4%
0.5%
0.5%
0.4%
$2M
$268000
$13M
Sep '24
$8M
$203000
21.5%
0.9%
0.8%
0.6%
-$5000
$288000
$10M
Jun '24
$6M
-$761000
24.3%
-14.2%
-3.1%
-2.2%
-$2M
$309000
$10M
Mar '24
$5M
-$1M
16.2%
-33.0%
-5.9%
-4.2%
-$2M
$330000
$12M
Dec '23
$4M
-$2M
-8.5%
-60.1%
-8.7%
-6.5%
-$240000
$349000
$14M
Sep '23
$6M
-$753000
25.6%
-15.9%
-2.7%
-2.0%
$674000
$368000
$14M
Jun '23
$5M
-$1M
27.4%
-24.3%
-3.9%
-3.0%
$2M
$309000
$13M
Mar '23
$9M
-$40000
28.0%
-2.2%
-0.1%
-0.1%
-$3M
$329000
$11M
Dec '22
$7M
$2M
27.6%
-3.1%
5.3%
4.1%
$2M
$426000
$14M
Sep '22
$8M
$63000
29.8%
1.5%
0.2%
0.2%
-$277000
$355621
$12M
Jun '22
—
-$839000
—
—
-3.0%
-2.5%
-$1M
—
$12M
Mar '22
—
-$997000
—
—
-3.5%
-3.1%
-$2M
—
$13M
Dec '21
—
-$1M
—
—
-4.1%
-3.4%
-$720838
$2M
$17M
Sep '21
—
$6M
—
—
19.7%
16.6%
-$2M
$0
$17M
Valuation over time
How the market has priced CVV against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 3.6× (Mar '23) to 1.7× (Sep '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is CVV growing its revenue and profit?
Over the past 5 years, CVD EQUIPMENT CORP's revenue has declined 0.0% per year. These are computed facts, not advice.
How much debt does CVV have?
As of FY2025, CVD EQUIPMENT CORP reported — of total debt against $9M of cash; operating income covered interest expense -146.9×.
What is CVV's profit margin?
In FY2025, gross margin was 28.3%, operating margin -7.4%, and net margin -6.1%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.